Nectin Therapeutics
Operator of a biotechnology company intended to treat solid and hematological malignancies. The company develops antibodies that overcome inhibitory pathways deployed by the tumors and help immune cel...
Valuation
$0
Share Price
N/A
Total Raised
$58M
Last Round
N/A